Loteprednol etabonate ophthalmic gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Loteprednol etabonate ophthalmic gel, covering 2020-09-03 to 2020-09-03. Get the full timeline:
Most recent: Clinical Trial Update: Loteprednol Etabonate Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery [Phase 3]